Niacinamide, also known as nicotinamide, is the amide form of vitamin B3 (niacin). It is a water-soluble, heat-stable, white crystalline compound that participates in cellular energy metabolism as a precursor to the coenzymes NAD⁺ (nicotinamide adenine dinucleotide) and NADP⁺. In skin biology, these coenzymes are essential for cellular repair, lipid synthesis, barrier function, and the regulation of melanogenesis.
Unlike niacin, niacinamide does not cause vasodilation or the characteristic 'niacin flush' — making it safe for topical application at concentrations up to 10% without irritation in most subjects. Its broad mechanism of action, exceptional tolerability, and compatibility with nearly all commonly used cosmetic actives have made it one of the most formulated actives in modern skincare.
Niacinamide operates across multiple independent skin benefit pathways simultaneously: it inhibits melanosome transfer from melanocytes to keratinocytes (brightening), stimulates ceramide and free fatty acid production (barrier repair), reduces sebum excretion rates (sebum control), downregulates inflammatory cytokine cascades (anti-redness), and supports NAD⁺-mediated DNA repair mechanisms (anti-aging). No other single cosmetic active addresses this breadth of mechanisms at typical-use concentrations.
Niacinamide's primary brightening mechanism involves the inhibition of melanosome transfer. Melanosomes — the organelles containing melanin — are produced in melanocytes and transferred to surrounding keratinocytes via a receptor-mediated process. Niacinamide interferes with the docking of melanosomes at the keratinocyte surface, reducing the amount of melanin distributed within the epidermis. This mechanism is distinct from and complementary to tyrosinase-inhibiting actives such as vitamin C or kojic acid, which act upstream on melanin synthesis itself.
For barrier function, niacinamide upregulates keratinocyte synthesis of key structural lipids — particularly ceramides, free fatty acids, and cholesterol — the three critical components of the lamellar lipid bilayer in the stratum corneum. This results in measurable reductions in TEWL and improvements in skin capacitance.
Its anti-sebum effect is mediated through inhibition of sebocyte lipogenesis, reducing the output of sebum independently of hormonal pathways — making it effective for sebum-related concerns without the systemic side effects of retinoids or antiandrogens.
Niacinamide is one of the few actives that simultaneously addresses brightening, barrier, sebum, inflammation, and aging through distinct, independent mechanisms — making it genuinely multi-functional rather than merely multi-claimed.
Niacinamide is one of the most clinically validated cosmetic actives available.
In 2002, a landmark double-blind study by Procter & Gamble demonstrated that 5% niacinamide, applied twice daily for 12 weeks, significantly improved hyperpigmentation, fine lines, red blotchiness, yellowing, elasticity, and overall skin texture. This study established niacinamide as a highly effective, multi-functional anti-aging active.
In 2006, a randomized controlled trial showed that 2% niacinamide reduced sebum excretion by 41% compared to placebo over 4 weeks, with efficacy comparable to clindamycin gel in reducing inflammatory acne lesions.
In 2011, a study published in Dermatologic Surgery reported that 4% niacinamide performed comparably to 4% hydroquinone in reducing melasma after 8 weeks—without the associated safety concerns of hydroquinone.
More recent work on niacinamide's NAD⁺ pathway effects has opened new possibilities in longevity-focused skincare, with studies showing improved skin elasticity, reduced pigmentation, and enhanced barrier function attributable to cellular metabolic support.
| INCI Name | Niacinamide |
| Other Names | Nicotinamide, Vitamin B3 |
| CAS Number | 98-92-0 |
| EC Number | 202-713-4 |
| Molecular Formula | C₆H₆N₂O |
| Molecular Weight | 122.13 g/mol |
| Appearance | White crystalline powder |
| Solubility | Freely soluble in water (1 g/mL); soluble in ethanol |
| pH Stability Range | 5.0 – 7.0 (optimal 6.0) |
| Recommended Usage | 2% – 10% (cosmetic applications) |
| Origin / Source | Chemical synthesis from nicotinic acid |
| Regulatory Status | CosIng listed | FDA GRAS | CDSCO compliant | IECIC listed |
Niacinamide has an excellent safety record across decades of clinical and consumer use, making it one of the most widely recommended actives by dermatologists for sensitive skin.
| Sensitization | Very low sensitization potential — suitable for sensitive and reactive skin types |
| Flushing | Unlike niacin, niacinamide does not cause vasodilatory flushing at cosmetic concentrations |
| Comedogenicity | Non-comedogenic; often beneficial for acne-prone skin |
| Irritation Potential | Non-irritating at 2–5%; mild tingling possible at 10%+ in sensitive subjects |
| Photosensitivity | Non-photosensitizing |
| Special Populations | Generally considered safe during pregnancy; consult dermatologist for medical-grade applications |
Niacinamide is a white crystalline powder that dissolves readily in water and is compatible with a very broad range of cosmetic systems. It is non-ionic, heat-stable, and can be added to the aqueous phase at any formulation stage. Its primary formulation challenge is a potential interaction with certain vitamin C forms at low pH — manageable with appropriate formulation design.
Inhibits melanosome transfer for visible pigmentation reduction and even skin tone
Multi-pathway anti-aging — lines, texture, elasticity, and barrier support
Reduces sebum excretion and inflammatory lesions without antibiotic resistance risk
Upregulates ceramide and fatty acid synthesis for structural barrier restoration
Gentle brightening and barrier support for the delicate periorbital zone
Lightweight delivery for daily multi-benefit application in layered routines
Soothing, anti-inflammatory, and barrier-supporting in post-peel and post-laser contexts
Body brightening and oil control; anti-pollution synergy in daily SPF formulations
| Minimum Efficacious | 2.0% w/w (sebum control, anti-inflammatory) |
| Standard Range | 4.0 – 5.0% w/w (brightening, anti-aging — most clinical studies) |
| High Dose | 10.0% w/w (maximum visible results; check tolerability for sensitive skin) |
Stable across pH 5.0 – 7.0. Optimal activity and stability at pH 6.0. At pH below 5.0, niacinamide may hydrolyse to nicotinic acid over time — which can cause skin flushing and is undesirable. For vitamin C serums at pH 3.0–3.5, formulating niacinamide and ascorbic acid together is possible but requires careful stability testing, as the combination can form a yellow adduct (nicotinamide-ascorbate) at elevated temperatures.
Niacinamide is heat-stable up to 120°C, allowing addition to hot-process phases. For economy, add to cooled aqueous phase post-emulsification.
| Compatible With | Use Caution With |
|---|---|
| Hyaluronic acid, glycerin, panthenol Ectoin, allantoin, centella asiatica Retinoids (complementary mechanisms) AHAs/BHAs (maintain pH ≥5.0) Peptides, ceramides Zinc compounds (synergistic for acne) | L-ascorbic acid at low pH (<3.5) — potential yellow discolouration Niacin (nicotinic acid) — verify purity to avoid flushing Copper peptides at high concentrations — monitor stability |
Niacinamide is a widely available commodity cosmetic ingredient. SBCT Labs does not currently manufacture niacinamide, but incorporates it at effective concentrations in several formulated complexes. For sourcing enquiries, we recommend established global suppliers including DSM, Lonza, Jubilant Life Sciences, and Vertellus. We welcome formulation discussions around niacinamide-containing complex actives using our other portfolio ingredients.
Niacinamide is one of the most universally accepted cosmetic actives globally — with no concentration restrictions in any major market and a long history of safe use.
Compliant with Indian Cosmetic Rules 2020. No concentration restrictions for topical cosmetic use. Extensively used in the Indian market at 2–10%.
Listed in the CosIng database. No Annex restrictions. Compliant with Regulation (EC) No. 1223/2009. One of the most widely used actives in EU-marketed skincare.
FDA GRAS status. No restrictions for topical cosmetic use. Widely recommended by US dermatologists at 2–10% concentrations.
Listed in the Inventory of Existing Cosmetic Ingredients in China. Approved for use in cosmetic products manufactured in or imported to China. No concentration limits documented for standard cosmetic applications.
A. Yes, with care. The concern about niacinamide and vitamin C forming nicotinamide-ascorbate (a yellow/orange adduct) is real but overstated at cosmetic use temperatures and concentrations. The reaction is temperature-dependent and slow at room temperature. Formulations combining both at pH 5.0–6.0 have been shown to be stable for 12+ months in standard shelf-life testing. The issue is most pronounced at pH below 3.5 with high ascorbic acid concentrations (≥10%) and elevated temperatures during storage.
A. Brightening efficacy has been demonstrated from 4% upward in clinical studies. At 2%, anti-inflammatory and sebum-controlling effects are more prominent than brightening. For visible pigmentation improvement, 5% is the standard reference dose from most published studies. Higher concentrations (up to 10%) deliver more pronounced results for hyperpigmentation.
A. Flushing is caused by nicotinic acid (niacin), not niacinamide. Cosmetic-grade niacinamide specifications allow a small percentage of nicotinic acid impurity. In high-dose products (>5%), formulating with pharmaceutical-grade niacinamide (≥99.5% purity with <0.05% nicotinic acid) eliminates this risk. If flushing is reported with a product, verify raw material purity.
A. Yes. At 2–4%, niacinamide reduces sebum excretion, decreases inflammatory lesion counts, and supports the skin barrier — all relevant to acne management. A 2006 RCT showed 2% niacinamide was comparable to clindamycin gel in reducing inflammatory acne. Unlike topical antibiotics, it carries no resistance risk and can be used long-term.
A. Niacinamide upregulates the expression of keratinocyte proteins involved in differentiation and barrier formation, including filaggrin, involucrin, and loricrin. More importantly for formulation purposes, it stimulates synthesis of ceramides, cholesterol, and free fatty acids — the three essential lipid classes of the stratum corneum's lamellar bilayer. This results in measurable reductions in TEWL and improved skin hydration metrics.
A. pH 5.5 – 6.5 is the optimal range. At pH 5.5–6.5, niacinamide is stable, soluble, and skin-compatible. Avoid formulating below pH 5.0 for niacinamide-primary products — the risk of hydrolysis to nicotinic acid increases over shelf life at lower pH values, particularly at warmer storage temperatures.
Disclaimer: Information on this page has been compiled from published scientific literature and industry reference sources. Formulation recommendations are general guidelines and should be validated through appropriate stability and compatibility testing for your specific product. SBCT Labs makes no warranty, expressed or implied, regarding the suitability of information for any particular application. Users are responsible for verifying safety, efficacy, and regulatory compliance for their intended use.